Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Stock Report

| More

ELGi's AB 'Always Better' Series powers the Indian pharmaceutical industry

Posted On: 2020-08-07 23:36:45 (Time Zone: Arizona, USA)


India's leading pharmaceutical companies rely on the ELGi ((BSE: 522074 NSE: ELGIEQUIP)) AB series range of oil free screw compressors, to deliver pure, clean, class "0" oil free air. With high reliability, consistent air quality, better return on investment, lower cost of ownership, and fast, efficient service support for sensitive applications with moisture content between +3C, to -20C PDP; the AB series range of air compressors meets the ISO 8573-1 compliance requirements. In addition, the ELGi AB Series delivers unmatched air quality in line with the ISO8573-Class 7 compliance norms ensuring zero traces of microbial contaminants. With the IS:10500:2012 certification for water quality, the AB series also guarantees the safest pneumatic air for the pharmaceutical industry. The sheer performance of the ELGi AB Series, coupled with its compelling value proposition has resulted in India's leading pharmaceutical companies replacing existing machines with the AB series, while successful installations, have prompted pharmaceutical companies, across the country, to revisit their entire fleet of air compressors.

India's pharmaceutical industry is forecasted to grow at 22.4% annually, to US $100 billion by 2025; addressing over 50% of the global demand for vaccines, 40% of generic demand in the US and 25% of all medicine requirements in the UK. Dr. Jairam Varadaraj, Managing Director, Elgi Equipments Ltd said "In light of the pandemic, India's pharmaceutical industry has a tremendous opportunity to play a pivotal role in global healthcare. With growing FDA scrutiny, strict warnings over toxic impurities and delicate pharmaceutical manufacturing processes, the quality of compressed air meeting the highest standards, is of quintessential importance. On the other hand, continuous air supply must be guaranteed, since a disruption can lead to an immense loss of production. At ELGi, we endeavoured to address the needs of the pharmaceutical manufacturing industry in a new way. The ELGi AB 'Always Better' series is a disruption in oil free compressed air technology, and we're delighted to witness its growing adoption as the customer's choice for sensitive pharmaceutical applications."

Pharmaceutical customers traditionally buy oil lubricated compressors for requirements below 500cfm (90kW) owing to low capital investments, and conventional oil free compressors, to meet stringent air quality requirements. The flip side of using lubricated screws is the multi-layer filtration systems which increase pressure drop and cause down time due to the replacement of oil filters resulting in increased lifecycle costs. On the other hand, conventional oil free compressors in this range, are normally air-cooled and also face reliability issues and temperature trips at high ambient temperature conditions (above 45C), resulting in significant downtime and operational losses, in addition to excessive initial and running costs.

The ELGi AB Series is the #Always better choice; offering pharmaceutical manufacturing customers reliability and high performance at temperatures beyond 50C due to the water injection inside the compression chamber. The AB Series delivers Class '0' quality air, while the water in the closed circuit is insulated with proprietary material to ensure zero contamination due to corrosion.

The ELGi AB Series has a unique air cooling system which ensures ample condensation of water from air particles, aiding the self-replenishment of water in the closed loop. This eliminates the need for external water top-up and also reduces the load on the driers and the water management system. The in-built microbial inhibition system prevents microbial growth, across all scenarios of operation, thereby ensuring microbe free air.

The ELGi AB Series operates with a single airend, as opposed to conventional oil free machines that operate with dual airends. This results in lower foot print, fewer rotating components and lower maintenance costs. Fitted with stainless steel rotors for better performance, every ELGi AB series air compressor comes with standard bearings for ease of maintenance. Additionally, the AB series range operates at a lower RPM, resulting in less wear and tear of rotating parts, low noise levels and reduced power consumption. Additionally, the low noise levels ensure the AB series does not require a dedicated compressor room and can be placed right next to the application area, thereby reducing costs involved with the build-up of additional infrastructure and compressed air supply systems.

Mr. Rajesh Premchandran, Director, ISAAME (India, South Asia, Africa and Middle East) said, "The AB Series is a disruption in oil free compressed air technology, offering pharmaceutical customers a no-compromise, oil free solution at reduced lifecycle costs when compared with prevailing oil free technologies. With the AB Series compressors, pharmaceutical installations get the purest form of compressed air with higher efficiency, increased reliability and quicker return on investment."

Shares of ELGI EQUIPMENTS LTD. was last trading in BSE at Rs.170.2 as compared to the previous close of Rs. 170.7. The total number of shares traded during the day was 1765 in over 179 trades.

The stock hit an intraday high of Rs. 170.8 and intraday low of 167.5. The net turnover during the day was Rs. 299177.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Hinduja Global Solutions Limited arm raises stake in HGS Digital LLC to 100%

Adani Green Energy Signs Agreement to Acquire 20 MW Operating Solar Asset for INR 133 cr

Steel Exchange India Limited receives OTS sanction letters from all lenders

DCB Bank Ltd posts Q3FY21 net profit of Rs. 96.21 crore

Vivanza Biosciences Ltd posts consolidated PAT of Rs. 0.16 crore in Q3

Arihant Superstructures Ltd Q3FY21 consolidated net profit at Rs. 1.94 crore

ICRA reaffirms rating of IIFL Finance Ltd, IIFL Home Finance Ltd

Zenotech Laboratories Ltd appoints Mr. Devendra Chandrakant S. Kenkre as CEO

Polycab India Ltd reports Q3FY21 consolidated PAT of Rs. 262.50 crore

JM Financial Ltd posts consolidated PAT of Rs. 180.76 crore in Q3 FY2020-21

Birla Corporation Ltd Q3FY21 consolidated PAT at Rs. 148.42 crores

Sportking India Ltd Q3 net profit zooms to Rs. 30.32 crore

APM Finvest Ltd Q3FY21 net profit jumps to Rs. 6.90 crore

Ultratech Cement Ltd reports jump in Q3FY21 consolidated PAT to Rs. 1584.34 crores

Supreme Industries Ltd Q3FY21 Q3FY21 consolidated PAT zooms to Rs. 312.28 crore

Mahindra Lifespaces achieves residential sales of Rs. 195 crores during Q3FY21 up 70% over Q2FY21

Rossari Biotech Ltd Q3FY21 consolidated PAT up at Rs. 21.60 crore

Vimta Labs Ltd Q3FY21 net profit up at Rs. 8.01 crore

Pudumjee Paper Products Ltd reports loss in Q3FY21

Zydus Cadila receives final approval from USFDA for Liothyronine Sodium Tablets

Tata Power Solar receives the EPC order for INR 1200 Crore from NTPC for setting up of 320MW ground mounted Solar PV project

Pil Italica Lifestyle Ltd Q3FY21 PAT at Rs. 2.02 crore

Apollo Hospitals Enterprise Limited raises funds through QIP at Rs. 2511 per share

Sadbhav Infrastructure Project Limited board to consider issue of NCDs

Wendt India Ltd board declares interim dividend of Rs. 10 for FY21

Kriti Nutrients Ltd Q3FY21 net profit at Rs. 3.56 crore

Jio Platforms Ltd Q3FY21 PAT rises 15.5% QoQ

Reliance Industries Ltd Q3FY21 consolidated net profit jumps to Rs. 13101 crore

IndiGo strengthens regional connectivity, launches Agra as 64th domestic destination

Kewal Kiran Clothing Ltd board declares 2nd interim dividend of Rs. 8

Isgec Bags prestigious orders for Air Pollution Control Equipment

Tata Motors increases passenger vehicle prices from today

Kewal Kiran Clothing Ltd Q3FY21 consolidated PAT at Rs. 10.84 crore

Fineotex Chemical Ltd Q3FY21 consolidated net profit up at Rs. 13.07 crore

Swaraj Engines Posts its Ever Best Q3 Performance

Crompton Greaves Consumer Electricals Ltd Q3FY21 consolidated net profit at Rs. 151.09 crore

Oberoi Realty Ltd posts consolidated PAT of Rs. 286.65 crore in Q3FY21

Gland Pharma Ltd Q3FY21 net profit at Rs. 204.10 crore

Aditya Birla Group flagship Grasim to foray into the Paints Business

OMAX Autos Ltd commences commercial production of new unit

Spark Minda appoints Mr. Biranchi Mohapatra as the CEO for Business Vertical II - Information and Connected Systems

IndiGrid increases distribution to INR 3.10 per unit / Quarter

NTPC to raise Rs. 2,500 crore through private placement of bods

Century Textiles & Industries Ltd posts consolidated PAT of Rs. 32.11 crores in Q3

YES Bank Ltd reports Q3FY21 consolidated PAT of Rs. 147.68 crore

SBI Life Insurance Company Ltd Q3FY21 PAT lower at Rs. 232.85 crore

Kriti Industries Ltd posts Rs. 17.74 crore consolidated PAT in Q3FY21

HDFC Life Insurance Company Ltd Q3FY21 consolidated PAT at Rs. 263.44 crore

JSW Steel Ltd posts consolidated PAT of Rs. 2681 crores in Q3 FY2020-21

Symphony Limited board declares interim dividend of Rs. 1 for FY21



Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020